person · Reporting owner
Charles Ron Christopher
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Chemours CoCC · Entity 4420 | Senior Vice President, People | May 08, 2024 | May 10, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Chemours Co
Report date May 08, 2024 · Filed May 10, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,736.4074 |
Reported balance
After 2024-05-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-05-08 · Grant · Acquired 4,545 · Balance 20,736.4074 F1: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2025. F2: Includes directly owned shares, restricted stock units and dividend equivalent units. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.50 · Expires 2034-05-08 | Direct | 12,159 |
Reported balance
After 2024-05-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-05-08 · Grant · Acquired 12,159 · Balance 12,159 F3: These options are scheduled to vest in three equal annual installments beginning on May 8, 2025. |
| Performance Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.25 · Expires 2034-05-08 | Direct | 12,645 |
Reported balance
After 2024-05-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-05-08 · Grant · Acquired 12,645 · Balance 12,645 F4: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant. F3: These options are scheduled to vest in three equal annual installments beginning on May 8, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2025.
F2: Includes directly owned shares, restricted stock units and dividend equivalent units.
F3: These options are scheduled to vest in three equal annual installments beginning on May 8, 2025.
F4: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2024 Filed May 10, 2024 20:03 UTC | Chemours Co CC · Entity 4420 | GrantPerformance Stock Option (Right to Buy) · Derivative | 12,645 | $0.00 Strike: $30.25 | $0.00 |
DisclosureSEC source: 0001062993-24-009872 · form4.xml · derivative · entry 3 Charles Ron Christopher · CIK 0001994298 · Senior Vice President, People 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,645 Underlying: Common Stock · 12,645 shares Expires 2034-05-08 F4 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant. F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on May 8, 2025. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:03 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 12,159 | $0.00 Strike: $27.50 | $0.00 |
DisclosureSEC source: 0001062993-24-009872 · form4.xml · derivative · entry 2 Charles Ron Christopher · CIK 0001994298 · Senior Vice President, People 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,159 Underlying: Common Stock · 12,159 shares Expires 2034-05-08 F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on May 8, 2025. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:03 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 4,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009872 · form4.xml · nonDerivative · entry 1 Charles Ron Christopher · CIK 0001994298 · Senior Vice President, People 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,736.4074 F1 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2025. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:02 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 968 | $20.78 | $20,115.04 |
DisclosureSEC source: 0001062993-24-005605 · form4.xml · nonDerivative · entry 1 Charles Ron Christopher · CIK 0001994298 · Senior Vice President, People 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,093.9748 F1 · kind: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:09 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 2,021 | $29.68 | $59,983.28 |
DisclosureSEC source: 0001062993-23-021907 · form4.xml · nonDerivative · entry 1 Charles Ron Christopher · CIK 0001994298 · Senior Vice President, People 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,983.1219 F1 · kind: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on December 1, 2024. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 21:45 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 2,547 | $24.44 | $62,248.68 |
DisclosureSEC source: 0001062993-23-020193 · form4.xml · nonDerivative · entry 1 Charles Ron Christopher · CIK 0001994298 · Senior Vice President, People 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,962.4716 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.